146 related articles for article (PubMed ID: 36144555)
1. Morin-VitaminE-β-CyclodextrinInclusionComplexLoadedChitosanNanoparticles (M-Vit.E-CD-CSNPs) Ameliorate Arsenic-Induced Hepatotoxicityina Murine Model.
Mondal S; Das S; Mahapatra PK; Saha KD
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144555
[TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin-Modified CeO
Wu L; Liu G; Wang W; Liu R; Liao L; Cheng N; Li W; Zhang W; Ding D
Int J Nanomedicine; 2020; 15():2515-2527. PubMed ID: 32368038
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization.
Ayumi NS; Sahudin S; Hussain Z; Hussain M; Samah NHA
Drug Deliv Transl Res; 2019 Apr; 9(2):482-496. PubMed ID: 29569027
[TBL] [Abstract][Full Text] [Related]
4. Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release.
Tang P; Yang H; Tang B; Wu D; Du Q; Xu K; Li H
Carbohydr Polym; 2017 Jan; 156():215-222. PubMed ID: 27842816
[TBL] [Abstract][Full Text] [Related]
5. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.
Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F
Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666
[TBL] [Abstract][Full Text] [Related]
6. Morin encapsulated chitosan nanoparticles (MCNPs) ameliorate arsenic induced liver damage through improvement of the antioxidant system and prevention of apoptosis and inflammation in mice.
Mondal S; Das S; Mahapatra PK; Saha KD
Nanoscale Adv; 2022 Jun; 4(13):2857-2872. PubMed ID: 36132010
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant, antibacterial and anti-cancer activities of β-and γ-CDs/curcumin loaded in chitosan nanoparticles.
Alizadeh N; Malakzadeh S
Int J Biol Macromol; 2020 Mar; 147():778-791. PubMed ID: 31982535
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery.
Khalil SK; El-Feky GS; El-Banna ST; Khalil WA
Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
Zhang P; Liu X; Hu W; Bai Y; Zhang L
Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746
[TBL] [Abstract][Full Text] [Related]
10. Preparation, Characterization, and
Zhang Z; Chen J; Zou L; Tang J; Zheng J; Luo M; Wang G; Liang D; Li Y; Chen B; Yan H; Ding W
Int J Nanomedicine; 2022; 17():5287-5302. PubMed ID: 36411767
[TBL] [Abstract][Full Text] [Related]
11.
Zhang L; Yang S; Wong LR; Xie H; Ho PC
Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and systemic application of self-assembled hydroxyethyl starch nanoparticles-loaded flavonoid Morin for hyperuricemia therapy.
Li J; Yang Y; Lu L; Ma Q; Zhang J
Int J Nanomedicine; 2018; 13():2129-2141. PubMed ID: 29692610
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W
Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276
[TBL] [Abstract][Full Text] [Related]
14. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
Zameer S; Ali J; Vohora D; Najmi AK; Akhtar M
J Drug Target; 2021 Feb; 29(2):199-216. PubMed ID: 32876502
[TBL] [Abstract][Full Text] [Related]
15. Utilization of Gelling Polymer to Formulate Nanoparticles Loaded with Epalrestat-Cyclodextrin Inclusion Complex: Formulation, Characterization, In-Silico Modelling and In-Vivo Toxicity Evaluation.
Alvi Z; Akhtar M; Rahman NU; Hosny KM; Sindi AM; Khan BA; Nazir I; Sadaquat H
Polymers (Basel); 2021 Dec; 13(24):. PubMed ID: 34960901
[TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T
Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293
[TBL] [Abstract][Full Text] [Related]
17. Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity.
Tang P; Sun Q; Zhao L; Pu H; Yang H; Zhang S; Gan R; Gan N; Li H
Carbohydr Polym; 2018 Oct; 198():418-425. PubMed ID: 30093018
[TBL] [Abstract][Full Text] [Related]
18. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of antioxidant nanoparticles composed of chitosan and fucoidan for antibiotics delivery.
Huang YC; Li RY
Mar Drugs; 2014 Jul; 12(8):4379-98. PubMed ID: 25089950
[TBL] [Abstract][Full Text] [Related]
20. Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Ibrutinib Delivery: A Potential Nanoformulation of Novel Kinase Inhibitor.
Zhao L; Tang B; Tang P; Sun Q; Suo Z; Zhang M; Gan N; Yang H; Li H
J Pharm Sci; 2020 Feb; 109(2):1136-1144. PubMed ID: 31606544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
